• Nagaland CM hails PM Modi’s ‘timely step’ to provide free vaccine
    Kohima, June 8 (MExN): Nagaland Chief Minister Neiphiu Rio has hailed the decision of the Government of India announced by Prime Minister, Narendra Modi on June 7 to provide free vaccine to all Indian citizens above 18 years of age as a ‘decisive and timely step.’ Taking to Twitter after the Prime Minister’s address to the nation on Monday, Rio said he was grateful to Modi for the “decisive & timely step to provide free vaccine to all Indian citizens abov
  • Collective responsibility on vaccines
    It is very encouraging to see that almost all slots for the 18-44 age group vaccination drive in Nagaland are filled up. The first session of vaccination drive for this particular age group began on May 17 and another session will be held across the State on May 18. Initial vaccine hesitancy seems to have dwindled a bit, given the enthusiasm shown as reflected in the slots being booked quickly and en masse. But this surge in demand for vaccination seems to have emerged mostly from t
  • US approves Johnson & Johnson's Covid vaccine
    February 28 (PTI): The United States Food and Drug Administration has approved Johnson and Johnson's COVID-19 vaccine that works with just one dose instead of two for emergency use, giving America its third jab to fight the pandemic that has claimed over half a million lives in the country. President Joe Biden described the FDA's approval as an encouraging development in efforts to end the COVID-19 crisis and said this is exciting news for all US citizens. The Johnson and
  • India's vaccine diplomacy garners praise from global media
    New Delhi, February 13 (IANS): India is being lavishly praised in the international media for its vaccine diplomacy and helping other countries in time of need. "India has emerged the surprise leader of the global vaccine diplomacy race. It has exported three times more doses than it's given its own citizens and can spare even more without hurting its own rollout", Eric Bellman of Wall Street Journal said in a tweet. Yaroslav Trofimov and Bellman wrote a piece
  • COVID-19: India now 3rd topmost country to give highest doses of vaccine
    New Delhi, February 7 (PTI): India has become the third topmost country in the world in terms of the number of COVID-19 vaccine doses administered, the Union Health Ministry said on Sunday. Only the United States and the United Kingdom remain ahead of India. The ministry said 12 states in India have vaccinated more than 2 lakh beneficiaries each. Uttar Pradesh alone accounts for 6,73,542 of all vaccinated beneficiaries. Till February 7, 8 am, a total of 57.75 lakh beneficiarie
  • Vaccination kicks off in B'desh, Hasina thanks India for 2 mn doses
    Dhaka, January 28 (IANS): Bangladesh Prime Minister Sheikh Hasina on Wednesday thanked the government of India for the gift of two million doses of Covid-19 vaccine while virtually inaugurating the mass vaccination drive in the country. A nurse named Runu Veronica Costa was administered the first vaccine dose in Bangladesh at the Kurmitola General Hospital (KGH) in Dhaka, watched virtually by the Prime Minister. Hasina also watched four others take the jab, before 21 more were vacci
  • Covaxin neutralizes UK variant of Covid: Study
    Hyderabad, January 27 (IANS): Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study. According to the research paper carried by bioRxiv, the preprint server for biology, the study has dispelled the uncertainty of possible neutralization escape. A group of researchers from Indian Council of Medical Research(ICMR), National Institute of Virology, Pune and Bharat Biotec
  • Indian Covid vaccine arrives in Nepal
    Kathmandu, January 21 (IANS): The Covid-19 vaccines that India has granted to Nepal arrived in Kathmandu on Thursday. Indian Ambassador to Nepal handed over the vaccines to Health Minister Hridesh Tripathi at a function held at the Kathmandu airport. The consignment of the 'Made in India' Covid vaccines took off for Nepal this morning. In a tweet, Indian External Affairs Minister S Jaishankar said: "Nepal receives Indian vaccines. Putting neighbours first, putting
  • Mild infection good sign, shows immune system responding to vax: AIIMS chief
    New Delhi, January 16 (IANS): AIIMS Director Dr Randeep Guleria on Saturday joined scores of healthcare workers across the country who were administered Covid-19 vaccine shots on the first day of the nationwide vaccination drive. Dr Guleria said mild infection or adverse reaction after vaccination is a good sign because it shows the immune system of the body is reacting to the vaccine and creating antibodies. Moments after Prime Minister Narendra Modi launched the vaccination drive
  • Two doses of vaccine will be needed 28 days apart: Govt
    New Delhi, January 12 (PTI): There will be a gap of 28 days between two doses of COVID-19 vaccine and its effectiveness will begin 14 days after the second dose, the Health Ministry said on Tuesday. Addressing a press briefing, Union Health Secretary Rajesh Bhushan said vaccine effectiveness will be seen only after 14 days. "So we urge people to keep following COVID appropriate behaviour," he said. Bhushan said there will be a gap of 28 days between two doses of COVI
  • Made in India vaccines most cost effective in the world: Modi
    New Delhi, January 11 (IANS): Prime Minister Narendra Modi on Monday emphasised that India is entering into a decisive battle against Covid-19, as the country prepares for the Made in India vaccination drive from January 16. Making the closing remarks at the meeting with the Chief Ministers on Covid vaccine roll-out, the Prime Minister said that the public representatives are not in the priority list and the first round of vaccines will be given to the frontline workers. He also sai
  • Covaxin generated excellent safety data, says Bharat Biotech
    Hyderabad, January 3 (IANS): Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat Biotech claimed on Sunday that its vaccine generated excellent safety data with robust immune responses to multiple viral proteins that persist. Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track r
  • DCGI approves Serum, Bharat Biotech vaccine for emergency use
    New Delhi, January 3 (IANS): Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving way for its roll-out and administration to millions. "After adequate examination, the CDSCO has decided to accept the recommendations of the Subject Expert Committee and acc
  • Govt, vaccine maker clarify after Haryana Min tests Covid +ve
    New Delhi, December 5 (PTI): Covaxin is a two-dose anti-coronavirus vaccine and Haryana health minister Anil Vij, who had volunteered for its phase-three trial, was given only the first dose, the Union health ministry clarified on Saturday hours after the minister announced that he has tested positive for COVID-19. Vij had offered to be the first volunteer in the phase three trials for Covaxin, an indigenous potential vaccine against COVID-19 being developed by Bharat Biotech in col
  • Q&A: Where are we in the COVID-19 vaccine race?
    NEW YORK (Reuters) - Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. As some companies close in on unveiling their initial findings - with Canadian and European regulators already reviewing early data on some vaccines - the following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed
  • WHO vaccine drive bedevilled by familiar question: who pays if things go wrong?
    BRUSSELS, October 15 (Reuters) - Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It's not clear and that's a big problem in the battle to beat COVID-19. The World Health Organization (WHO) has so far left the question of financial claims unresolved as it seeks to ensure shots are fairly distributed around the world, according to confidential documents reviewed by Reuters and six people familiar with discussions
  • Pak hopeful of acquiring Covid-19 vaccine within the next 6 months
    Islamabad, October 12 (IANS): A Pakistani official from the Ministry of National Health Services has expressed hope that the country would acquire a vaccine against the novel coronavirus in the next six months. The official said on Sunday that Pakistan has also prepared antibodies against spike proteins, Dawn news reported. "At present, 15 vaccines were in phase-III trial globally out of which 11 target the spike protein," he said. The official said the vaccine might
  • 'Work risk, disease severity to be factors in vaccine dispensing'
    New Delhi, October 11 (IANS) The government would look at two key considerations for prioritisation of the Covid-19 vaccine -- the occupational hazard and risk of exposure to infection, and secondly, the risk of developing severe disease and increased mortality, Union Health Minister Harsh Vardhan said on Sunday. Besides, the supply of vaccines is anticipated to be available in limited quantities in the beginning, he added, during 'Sunday Samvaad', a weekly webinar which he
  • India to have coronavirus vaccine by 2020 end: Harsh Vardhan
    New Delhi, August 22 (IANS): Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year. Speaking to reporters here, he said that a Covid-19 vaccine is likely in the next 4-5 months. "I hope that if everything goes well, India will have access to a coronavirus vaccine by the end of 2020," the minister tweeted later. The Ministry of Health and Family Welfare said
  • Russia becomes first country to approve a COVID-19 vaccine, says Putin
    MOSCOW, August 11 (Reuters): President Vladimir Putin said on Tuesday that Russia had become the first country in the world to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess. The development paves the way for the mass inoculation of the Russian population, even as the final stage of clinical trials to test safety and efficacy continue.    The speed at which R